Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated the efficacy and safety of the valsartan/amlodipine combination in hypertensive patients not controlled on valsartan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED